Myovant Sciences Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Myovant Sciences Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $20.98 million as of 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2022-05-11
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $20.98M.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $58.42M.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.69M.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $23.34M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2022-03-31 | $20.98M 10-K · filed 2022-05-11 |
| 2021-03-31 | $58.42M 10-K · filed 2021-05-11 |
| 2020-03-31 | $3.69M 10-K · filed 2020-05-18 |
| 2019-03-31 | $23.34M 10-K · filed 2019-05-24 |
| 2018-03-31 | $8.23M 10-K · filed 2018-06-07 |
| 2017-03-31 | $110.00 10-K · filed 2017-06-14 |